ANAB AnaptysBio, Inc.

25.70
-1.00  -4%
Previous Close 26.70
Open 26.15
Price To book 4.91
Market Cap 520.91M
Shares 20,269,000
Volume 56,587
Short Ratio 2.50
Av. Daily Volume 75,028

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2a trial initiated 1Q 2017 with data due 2H 2017.
ANB020
Moderate-to-severe adult atopic dermatitis
Phase 2a data due 1H 2018.
ANB020
Severe adult eosinophilic asthma
Phase 2a trial initiated 1Q 2017 with data due 2H 2017.
ANB020
Severe adult peanut allergy